The exact clinical proportion of de novo versus inherited YWHAG mutation cases is unknown, although recent cohort data suggest that the vast majority, up to 86.7%, are de novo, as reported in a study of 15 individuals with YWHAG-related epilepsy (Tan et al., 2025). The gene discussed is YWHAG; the disease is epilepsy.